Acumen Pharmaceuticals, Inc.
ABOS
DELAYED 1 MONTH
11 insider filings · Latest: Jun 9, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 10 8:51 PM | Nathan B FountainDirector | Sale | 6,400 | $2.23 | $14.3K | 48,150(D) | View → |
| Mar 6, 2026 | Mar 11 1:45 AM | Derek M MeisnerChief Legal Officer & Corp Sec | Sale | 2,090 | $3.26 | $6.8K | 173,999(D) | View → |
| Feb 27, 2026 | Mar 4 2:42 AM | Derek M MeisnerChief Legal Officer & Corp Sec | Sale | 9,406 | $3.01 | $28.3K | 173,999(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5 9:12 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Grant/Award | 53,250 | $2.29 | 53,250(I) | View → |
| Jun 3, 2026 | Jun 5 8:32 PM | Nathan B FountainDirector | Grant/Award | 53,250 | $2.29 | 53,250(D) | View → |
| Jun 3, 2026 | Jun 5 8:31 PM | Kimberlee C DrapkinDirector | Grant/Award | 53,250 | $2.29 | 53,250(D) | View → |
| Jun 3, 2026 | Jun 5 8:30 PM | John A Stalfort IIIDirector | Grant/Award | 53,250 | $2.29 | 53,250(D) | View → |
| Jun 3, 2026 | Jun 5 8:30 PM | Derrell PorterDirector | Grant/Award | 53,250 | $2.29 | 53,250(D) | View → |
| Jun 3, 2026 | Jun 5 8:29 PM | Jeffrey L. IvesDirector | Grant/Award | 53,250 | $2.29 | 53,250(D) | View → |
| Jun 3, 2026 | Jun 5 8:28 PM | George GolumbeskiDirector | Grant/Award | 53,250 | $2.29 | 53,250(D) | View → |
| Jun 3, 2026 | Jun 5 8:27 PM | Laura StoppelDirector | Grant/Award | 53,250 | $2.29 | 53,250(D) | View → |
| Mar 6, 2026 | Mar 11 1:45 AM | Derek M MeisnerChief Legal Officer & Corp Sec | Option Exercise | 2,090 | $1.85 | 71,048(D) | View → |
| Feb 27, 2026 | Mar 4 2:42 AM | Derek M MeisnerChief Legal Officer & Corp Sec | Option Exercise | 9,406 | $1.85 | 73,138(D) | View → |